NIKITA SHUKLA to Immunologic Factors
This is a "connection" page, showing publications NIKITA SHUKLA has written about Immunologic Factors.
Connection Strength
0.655
-
Real-World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease-Modifying Therapy in Pediatric Multiple Sclerosis. Ann Neurol. 2026 03; 99(3):715-729.
Score: 0.207
-
Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry. J Child Neurol. 2026 04; 41(4):545-555.
Score: 0.205
-
Limited early IVIG for the treatment of pediatric myelin oligodendrocyte glycoprotein antibody-associated disease. Mult Scler Relat Disord. 2025 May; 97:106345.
Score: 0.197
-
Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumab. Mult Scler Relat Disord. 2024 Jul; 87:105647.
Score: 0.046